| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/01/2023 | Sensei Biotherapeutics, Inc. | | Sale | | 2.5M | $1.58 | $3.9M | By Apeiron Investment Group Ltd. | 06/01/2023 |
| 06/01/2023 | Sensei Biotherapeutics, Inc. | | Sale | | 955.7k | $1.58 | $1.5M | By Presight Sensei Co-Invest Fund, L.P. | 06/01/2023 |
| 02/23/2023 | Sensei Biotherapeutics, Inc. | | Purchase | | 1.1k | $1.62 | $1.8k | By Apeiron Investment Group Ltd. | 02/23/2023 |
| 02/23/2023 | Sensei Biotherapeutics, Inc. | | Purchase | | 1.1k | $1.60 | $1.8k | By Apeiron Investment Group Ltd. | 02/23/2023 |
| 04/29/2022 | ATAI Life Sciences N.V. | | Purchase | Common Shares | 21.9k | $4.47 | $97.8k | By Apeiron Presight Capital Fund II, L.P. | 04/28/2022 |
| 04/28/2022 | ATAI Life Sciences N.V. | | Purchase | Common Shares | 34.7k | $4.46 | $154.7k | By Apeiron Presight Capital Fund II, L.P. | 04/28/2022 |
| 04/25/2022 | ATAI Life Sciences N.V. | | Purchase | Common Shares | 9k | $4.78 | $42.8k | By Apeiron Presight Capital Fund II, L.P. | 04/22/2022 |
| 04/22/2022 | ATAI Life Sciences N.V. | | Purchase | Common Shares | 52.8k | $4.83 | $255k | By Apeiron Presight Capital Fund II, L.P. | 04/22/2022 |
| 04/21/2022 | ATAI Life Sciences N.V. | | Purchase | Common Shares | 68.7k | $4.95 | $340k | By Apeiron Presight Capital Fund II, L.P. | 04/20/2022 |
| 04/20/2022 | ATAI Life Sciences N.V. | | Purchase | Common Shares | 67.7k | $5.09 | $344.5k | By Apeiron Presight Capital Fund II, L.P. | 04/20/2022 |
| 04/19/2022 | ATAI Life Sciences N.V. | | Purchase | Common Shares | 65.3k | $5.13 | $334.7k | By Apeiron Presight Capital Fund II, L.P. | 04/18/2022 |
| 04/18/2022 | ATAI Life Sciences N.V. | | Purchase | Common Shares | 54.3k | $5.11 | $277.7k | By Apeiron Presight Capital Fund II, L.P. | 04/18/2022 |
| 04/14/2022 | ATAI Life Sciences N.V. | | Purchase | Common Shares | 5k | $5.19 | $25.8k | By Apeiron Presight Capital Fund II, L.P. | 04/14/2022 |
| 04/12/2022 | ATAI Life Sciences N.V. | | Purchase | Common Shares | 55.2k | $4.88 | $269.6k | By Apeiron Presight Capital Fund II, L.P. | 04/12/2022 |
| 04/11/2022 | ATAI Life Sciences N.V. | | Purchase | Common Shares | 53.9k | $4.83 | $260.6k | By Apeiron Presight Capital Fund II, L.P. | 04/08/2022 |
| 04/08/2022 | ATAI Life Sciences N.V. | | Purchase | Common Shares | 57.7k | $4.81 | $277.6k | By Apeiron Presight Capital Fund II, L.P. | 04/08/2022 |
| 04/06/2022 | ATAI Life Sciences N.V. | | Purchase | Call Option (right to purchase) | 1000k | $10.10 | $10.1M | By Apeiron Investment Group Ltd. | 04/06/2022 |
| 06/22/2021 | ATAI Life Sciences N.V. | | Purchase | Common Shares | 700k | $15.00 | $10.5M | By Apeiron Investment Group Ltd. | 06/22/2021 |